Decompensated Cirrhosis
Decompensated cirrhosis is the stage at which chronic liver disease progresses from compensated structural damage to overt clinical failure. It is defined by the development of complications such as ascites, variceal bleeding, hepatic encephalopathy, and hepatorenal syndrome. At this point, the liver can no longer maintain adequate metabolic, synthetic, or circulatory function. Decompensation reflects both worsening hepatic architecture and profound systemic haemodynamic changes. Understanding this stage explains why patients often deteriorate rapidly and unpredictably.
What You Need to Know
Decompensated cirrhosis represents the point at which the liver can no longer maintain physiological stability despite long-standing structural damage. In compensated cirrhosis, hepatocytes and vascular adaptations preserve essential functions even as fibrosis distorts normal architecture. Decompensation occurs when these adaptive mechanisms fail and portal hypertension becomes severe enough to produce clinical consequences. The development of a single complication signals a fundamental shift in disease behaviour rather than gradual progression.
Portal hypertension is the central driver of decompensation. Fibrosis and regenerative nodules increase resistance to portal blood flow, raising pressure within the portal venous system and diverting blood away from the liver through collateral pathways. This haemodynamic disruption affects multiple organ systems simultaneously:
formation of portosystemic collaterals with risk of variceal bleeding
transudation of fluid into the peritoneal cavity leading to ascites
reduced effective arterial blood volume impairing renal perfusion
worsening hepatic clearance of toxins contributing to systemic effects
As portal pressure rises, hepatic synthetic failure becomes clinically evident. Reduced albumin production lowers oncotic pressure, exacerbating ascites and peripheral oedema, while impaired synthesis of clotting factors produces a fragile haemostatic balance. These changes reflect loss of functional liver mass rather than isolated laboratory abnormalities and contribute to the instability seen in decompensated disease.
Alcohol plays a major role in both triggering and perpetuating decompensation. Ongoing exposure sustains hepatocyte injury, amplifies inflammatory signalling, and accelerates fibrotic progression, directly worsening portal hypertension. Alcohol also increases susceptibility to acute decompensating events such as infection and gastrointestinal bleeding by impairing immune function and vascular integrity. Continued intake therefore transforms a potentially stable chronic condition into a progressive, high-risk systemic disorder with markedly reduced survival.
Beyond the Basics
Loss of Hepatic Reserve
In compensated cirrhosis, surviving hepatocytes adapt to progressive fibrosis by increasing functional output, allowing essential metabolic, synthetic, and detoxification processes to continue despite architectural distortion. As fibrosis advances and regenerative nodules replace normal parenchyma, the absolute number of functioning hepatocytes declines and this adaptive capacity narrows. Hepatic reserve is gradually exhausted, meaning the liver can no longer buffer physiological stress.
Once reserve is lost, minor insults such as infection, bleeding, dehydration, or alcohol exposure can precipitate abrupt deterioration. This explains why decompensation often appears sudden despite years of relatively stable disease, reflecting failure of compensatory capacity rather than rapid structural change.
Portal Hypertension as the Central Driver
Portal hypertension is the dominant haemodynamic abnormality in decompensated cirrhosis. Fibrosis and nodular regeneration increase intrahepatic vascular resistance, raising portal venous pressure and altering normal blood flow patterns. As pressure rises, blood is diverted through collateral pathways that bypass hepatic processing.
These changes lead to splanchnic vasodilation, ascites formation, and variceal development while simultaneously reducing effective arterial blood volume. The degree of portal hypertension closely correlates with the likelihood of decompensation and mortality because it disrupts circulation at both the hepatic and systemic levels.
Systemic Circulatory Dysfunction
Decompensated cirrhosis produces a hyperdynamic but ineffective circulation. Widespread splanchnic vasodilation lowers systemic vascular resistance, resulting in arterial hypotension despite increased total blood volume. Baroreceptor-mediated neurohormonal activation attempts to restore perfusion by retaining sodium and water and increasing cardiac output. Rather than correcting the problem, these responses worsen fluid overload, ascites, and dilutional hyponatraemia. Renal perfusion becomes increasingly compromised, predisposing to functional renal failure and further destabilising the circulatory state.
Immune Dysfunction and Inflammation
Cirrhosis is associated with profound immune dysregulation. Reduced hepatic clearance of bacteria and endotoxins, combined with impaired innate immune function, increases susceptibility to infection. At the same time, systemic inflammatory activity is heightened, particularly during episodes of acute decompensation. Infections, such as spontaneous bacterial peritonitis amplify vasodilation and inflammatory signalling, rapidly worsening circulatory and renal dysfunction. This bidirectional relationship explains why infection is both a frequent trigger of decompensation and a consequence of advanced disease.
Alcohol and Acute-on-Chronic Liver Failure
Alcohol is a major precipitant of acute deterioration in decompensated cirrhosis. Continued intake promotes hepatocyte injury through oxidative stress, mitochondrial dysfunction, and inflammatory activation, accelerating loss of hepatic reserve. Alcohol also worsens portal hypertension and increases vulnerability to infection and gastrointestinal bleeding. In this setting, alcohol exposure can precipitate acute-on-chronic liver failure, characterised by rapid onset of multi-organ dysfunction. Disease progression reflects overwhelming systemic stress imposed on an already fragile physiological state rather than isolated hepatic injury alone.
Clinical Connections
Decompensated cirrhosis commonly presents with ascites, jaundice, hepatic encephalopathy, or gastrointestinal bleeding, reflecting failure of hepatic reserve and clinically significant portal hypertension. Patients often fluctuate between periods of relative stability and acute deterioration because the underlying haemodynamic and immune abnormalities persist even when symptoms temporarily improve. Each episode of decompensation signals further loss of physiological reserve, explaining the sharp rise in mortality after the first event.
Care priorities are determined by the mechanisms driving instability rather than by liver disease alone. Portal hypertension, circulatory dysfunction, immune paresis, and impaired synthetic function create predictable patterns of clinical risk:
ascites and oedema due to sodium retention, hypoalbuminaemia, and splanchnic vasodilation
encephalopathy from reduced hepatic detoxification and altered cerebral perfusion
gastrointestinal bleeding related to collateral vessel formation and fragile haemostasis
infection and renal dysfunction driven by immune impairment and reduced effective arterial volume
Early recognition of these complications is critical because deterioration can accelerate rapidly once compensatory mechanisms fail. Close attention to fluid status, renal perfusion, mental state, and infection markers allows intervention before progression to multi-organ failure. Preventing precipitating factors such as infection, bleeding, dehydration, and alcohol exposure reduces the likelihood of recurrent decompensation, while consistent adherence to therapy and dietary measures supports residual hepatic function. Management therefore centres on anticipating physiological consequences of portal hypertension and hepatic failure rather than reacting to late clinical collapse alone.
Concept Check
What distinguishes compensated from decompensated cirrhosis?
Why is portal hypertension central to decompensation?
How does circulatory dysfunction contribute to ascites and renal failure?
Why are infections common in decompensated cirrhosis?
How does ongoing alcohol intake affect prognosis?